Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 356

1.

Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.

Fan Z, Huang XL, Kalinski P, Young S, Rinaldo CR Jr.

Clin Vaccine Immunol. 2007 Sep;14(9):1127-37. Epub 2007 Jul 18.

2.

Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Zhang S, Kodys K, Li K, Szabo G.

Gastroenterology. 2013 Feb;144(2):414-425.e7. doi: 10.1053/j.gastro.2012.10.034. Epub 2012 Oct 23.

3.

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.

Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8.

PMID:
21786458
4.

Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity.

Huang XL, Fan Z, Borowski L, Rinaldo CR.

J Leukoc Biol. 2008 Jun;83(6):1530-40. doi: 10.1189/jlb.1107795. Epub 2008 Mar 25.

PMID:
18364435
5.

Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.

Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M.

J Immunol. 1999 May 1;162(9):5584-91.

6.

HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

Smed-Sörensen A, Loré K, Walther-Jallow L, Andersson J, Spetz AL.

Blood. 2004 Nov 1;104(9):2810-7. Epub 2004 Jul 1.

8.

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection.

Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, Lederman MM, Lehmann PV, Valdez H.

J Immunol. 2004 Apr 15;172(8):4907-16.

9.

Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.

Gelderblom HC, Nijhuis LE, de Jong EC, te Velde AA, Pajkrt D, Reesink HW, Beld MG, van Deventer SJ, Jansen PL.

Liver Int. 2007 Sep;27(7):944-53.

PMID:
17696933
10.

Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.

Smith KN, Mailliard RB, Piazza PA, Fischer W, Korber BT, Fecek RJ, Ratner D, Gupta P, Mullins JI, Rinaldo CR.

MBio. 2016 May 31;7(3). pii: e00473-16. doi: 10.1128/mBio.00473-16. Erratum in: MBio. 2016;7(4). pii: e01012-16. doi: 10.1128/mBio.01012-16.

11.

Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma.

Kitahara M, Mizukoshi E, Nakamoto Y, Mukaida N, Matsushima K, Kaneko S.

Int Immunopharmacol. 2014 Aug;21(2):346-53. doi: 10.1016/j.intimp.2014.05.023. Epub 2014 Jun 2.

PMID:
24893118
12.

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

MacParland SA, Fadel SM, Mihajlovic V, Fawaz A, Kim C, Rahman AK, Liu J, Kaul R, Kovacs C, Grebely J, Dore GJ, Wong DK, Ostrowski MA.

PLoS One. 2016 Apr 28;11(4):e0154433. doi: 10.1371/journal.pone.0154433. eCollection 2016.

13.

Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection.

Szabo G, Dolganiuc A, Mandrekar P, White B.

Alcohol. 2004 Jul;33(3):241-9.

PMID:
15596093
14.

Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.

Díaz-Valdés N, Manterola L, Belsúe V, Riezu-Boj JI, Larrea E, Echeverria I, Llópiz D, López-Sagaseta J, Lerat H, Pawlotsky JM, Prieto J, Lasarte JJ, Borrás-Cuesta F, Sarobe P.

Hepatology. 2011 Jan;53(1):23-31. doi: 10.1002/hep.23980. Epub 2010 Dec 13.

PMID:
21154952
15.

Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.

Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, Heim MH, Battegay M, Genné D, Mulhaupt B, Malinverni R, Oneta C, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers JJ, Pantaleo G, Dutoit V.

Eur J Immunol. 2008 Oct;38(10):2665-77. doi: 10.1002/eji.200838336.

16.
17.

Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.

Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M.

BMC Immunol. 2008 Jun 13;9:28. doi: 10.1186/1471-2172-9-28.

18.

HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.

Fang Z, Zhu K, Guo N, Zhang N, Guan M, Yang C, Pan Q, Wei R, Yang C, Deng C, Liu X, Zhao P, Leng Q.

Pharm Res. 2015 Mar;32(3):741-8. doi: 10.1007/s11095-013-1050-3. Epub 2013 Apr 26.

PMID:
23619596
19.
20.

Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.

Shiina M, Rehermann B.

Hepatology. 2008 Feb;47(2):385-95.

PMID:
18064579

Supplemental Content

Support Center